BioSpace News Archive

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and commercialization of innovative diagnostic and therapeutic agents and products, today announced Bob Marshall, Chief Financial Officer and Treasurer, will present at the 2020 Evercore ISI HealthCONx Conference at 3:30 p.m. ET on Tuesday, December 1

Sunshine Biopharma Inc., a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs announced that it is pushing ahead with its Anti-Coronavirus drug development program.

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that Julian Adams, Chief Executive Officer of Gamida Cell, will present at two virtual conferences in December

The leading dermatology practice in the Northeast appears on Crain’s annual list of the fastest growing businesses for fourth consecutive year.

Braid Health has secured FDA clearance for its AI-powered diagnostic collaboration software, improving diagnostic access and reducing costs for large healthcare systems, urgent care clinics, and retail clinics.

City of Hope has initiated a phase 1 clinical trial that will test one of its investigational SARS-CoV-2 vaccines in healthy volunteers between the ages of 18 and 55 who have not had COVID-19.

Annual program honors individuals for their outstanding efforts in making a difference for patients living with myeloproliferative neoplasms (MPNs)

NeuroRx, Inc., and Relief AG (SIX: RLF, OTCQB: RLFTF), announce that more than 175 patients with Critical COVID-19 and Respiratory Failure who also have a severe comorbidity have now been entered into an Expanded Access Protocol (EAP) with RLF-100TM in the United States.

Remotely controlled hospital wards may sound like something out of science fiction, but they’re already becoming reality, and an innovation that could save time and even lives during the COVID-19 pandemic.

Afya Limited, or Afya (Nasdaq: AFYA), today announced that it will report third quarter 2020 financial results for the period ended September 30, 2020, following the close of the market on Thursday, December 3rd, 2020.